Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nurix Therapeutics Inc shares valued at $128,017 were sold by Ring Christine on Oct 01 ’24. At $22.23 per share, Ring Christine sold 5,760 shares. The insider’s holdings dropped to 24,592 shares worth approximately $0.54 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, CHRISTINE RING purchased 9,050 shares, netting a total of over 203,354 in proceeds.
Before that, Ring Christine had sold 9,050 shares from its account. In a trade valued at $225,736, the Chief Legal Officer traded Nurix Therapeutics Inc shares for $24.94 each. Upon closing the transaction, the insider’s holdings decreased to 9,050 shares, worth approximately $0.54 million.
Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in late July. Earlier on March 09, 2023, Barclays initiated its rating. Their recommendation was “an Overweight” for NRIX stock.
Analyzing NRIX Stock Performance
During the last five days, there has been a surge of approximately 0.88%. Over the course of the year, Nurix Therapeutics Inc shares have jumped approximately 111.82%. Shares of the company reached a 52-week high of $26.31 on 09/18/24 and a 52-week low of $7.65 on 01/29/24. A 50-day SMA is recorded $23.14, while a 200-day SMA reached $16.51. Nevertheless, trading volume fell to 4.09 million shares from 0.43 million shares the previous day.
Support And Resistance Levels for Nurix Therapeutics Inc (NRIX)
According to the 24-hour chart, there is a support level at 21.26, which, if violated, would cause prices to drop to 20.67. In the upper region, resistance lies at 22.26. The next price resistance is at 22.67. RSI (Relative Strength Index) is 40.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.62, which suggests the price will decrease in the coming days. Percent R is at 82.63%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
